FOR IMMEDIATE RELEASE
inSeption Group Partners with Pennsylvania Biotechnology Center to Support Early-Stage Biotech Companies
Audubon, PA, January 7, 2025 — inSeption Group is proud to announce its strategic partnership with the Pennsylvania Biotechnology Center (PABC) as the exclusive outsourcing partner for the PABC and B+Labs community. Through this collaboration, inSeption Group will provide crucial strategic guidance and support to early-stage biotech companies in the PABC ecosystem, helping them navigate the complexities of early trial planning and development.
This partnership aligns with both organizations’ missions to accelerate life sciences innovations and enhance support for emerging biotech companies. As the exclusive partner, inSeption Group will deliver its industry-leading expertise in clinical outsourcing, offering tailored services to streamline early development processes and expedite the path from discovery to clinical trials.
“Our collaboration with the Pennsylvania Biotechnology Center represents a shared commitment to supporting early-stage companies at the most critical points in their development journey,” said Joe Arcangelo, Co-Founder and Managing Director of inSeption Group. “By providing customized guidance and strategic planning, we aim to empower these innovators to achieve their clinical milestones more efficiently and successfully.”
Supporting the Growth of Philadelphia’s Life Sciences Ecosystem
The PABC has established itself as a leader in nurturing the next generation of biotech innovators. By leveraging inSeption Group’s extensive experience in trial planning and clinical research, the partnership aims to equip member companies with the resources and expertise necessary for successful trial execution and regulatory compliance.
“We are thrilled to welcome inSeption Group as a partner,” said Lou Kassa, Chief Executive Officer, Pennsylvania Biotechnology Center. “Their hands-on experience and commitment to client success align perfectly with our mission to support our member companies. Together, we can provide the strategic and operational support necessary for these companies to thrive.”
About inSeption Group
Founded in 2011, inSeption Group was created with the vision to restore business trust and confidence in the clinical outsourcing industry. inSeption Group delivers an unparalleled level of service to biotech and pharma companies conducting clinical programs and submissions in highly complex therapeutic areas such as oncology, neurodegenerative disorders, and rare diseases. inSeption expertise spans the clinical research lifecycle including early trial planning, project management, regulatory submissions support, and more. Over time, it has become a home for a subset of professionals who hold themselves to high standards of quality and personal accountability. In the changing landscape of clinical research, we’re creating a new kind of future. One where integrity outweighs self-interest, where transparency cultivates trust, and where people deliver on their promises. For more information, please visit our website at inseptiongroup.com and follow us on LinkedIn.
About the Pennsylvania Biotechnology Center (PABC)
The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advance biotechnology, and maximize synergies among nonprofit scientists and their commercial colleagues. The PABC has nearly 100 member companies and organizations, mostly small to mid-size science, research, and pharmaceutical companies. Nearly 50 of these companies operate on the Doylestown campus, which is home to the Hepatitis B Foundation and the Blumberg Institute. The PABC also manages B+Labs at Cira Centre, a new incubator in Philadelphia, in partnership with Brandywine Realty Trust. PABC companies have produced numerous FDA-approved drugs and medical devices, with a recent study showing that the PABC’s economic impact exceeded $7.3 billion and created more than 1,100 new jobs during 2016-2021.
For more information, please visit our website and follow us on LinkedIn, Instagram, Twitter (@BiotechnologyPa), and Facebook.
Media Contact:
Kristin Morris
Senior Director, Corporate Communications
kmorris@inseptiongroup.com
267-397-8980
870 W Main Street | Landsdale, PA
